News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Who Owns CRISPR?
Jenny Rood | Apr 3, 2015
With one US patent awarded and many other applications under consideration for the popular genome-editing technology, companies are adopting multiple strategies to navigate the complex intellectual property landscape.
Of Cells and Limits
Anna Azvolinsky | Mar 1, 2015
Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.
Keeping Up with IP
Kate Yandell | Sep 1, 2014
It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.
Patent Plea Ping Pong
Kerry Grens | Aug 21, 2014
A genetic testing firm accused of infringing upon Myriad Genetics’s gene patents fights back in an attempt to wipe other patents out.
Guidelines for Gene Patent Ruling
Jef Akst | Mar 7, 2014
The USPTO offers guidance to its patent examiners on how to interpret the Supreme Court’s rulings in the recent Myriad and Prometheus cases.
Consent at Last
Erin Weeks | Sep 18, 2013
A working group including members of the Lacks family approves the first projects to use the HeLa genome.
Opinion: AIA Does Not Discriminate
G. Nagesh Rao | Aug 21, 2013
The America Invents Act (AIA) was a step in the right direction for US competitiveness and open innovation.
Opinion: Racing Toward Invention
George Lewis | Jul 23, 2013
A newly instated patent law discriminates against academics and small biotechs.
Opinion: On Patenting Genes
Joan Ellis | Jun 18, 2013
The scientific community and the impact of the Myriad Genetics Supreme Court decision
Ruffled Feathers over a Viral Patent
Kate Yandell | May 30, 2013
The researchers who first identified a novel coronavirus say they have shared the virus freely.